DIRS.INFO The most relevant business & tech news

☆ MDMA therapy could be legalized by summer. Why are so many advocates sounding the alarm?
▼ + stars: | 2024-05-13 | by ( Anna Silman | ) www.businessinsider.com time to read: +52 min

Last summer, thousands of tie-dyed Burners and Patagonia-clad tech founders converged on the MAPS Psychedelic Science conference in Denver. The experience "broke the spell of this trauma, and she was able to rebuild her life," Doblin told The Guardian . The video team's job was to store recordings of every MDMA therapy session performed in the clinical trials. Grof believes in something called an "inner healing intelligence," an innate capacity for self-healing that psychedelic therapy helps unleash. Another time, a patient who had come to an MDMA therapy session later acknowledged they had been under the influence of LSD during treatment.

Persons: Jaden Smith, Aaron Rodgers, bro, Andrew Huberman, Rick Doblin, Doblin, mainstreaming psychedelics, influencers, Johnson, Elizabeth Nielson, Aubrey Marcus, ayahuasca, Matthew Stockman, Helena —, Timothy Leary, —, Hitler, Stanislav Grof, zombified, Brad Burge, Michael Mithoefer, Annie Mithoefer, Oprah, Sen, Joe Biden, MDMA's neurotoxicity, they'd, Albert Hofmann, David Bronner, Dr, Joe's, Bronner, Bronner's, Richard Rockefeller, John D, Rockefeller Jr, Rockefeller, Neşe, Johns Hopkins, who's, Devenot, Rick Friedman, Betty Aldworth, MAPS's multimillionaire, Tim Ferriss, Cody Swift, Zendo, Aldworth, Erica Siegal, Seth Whitelaw, Amy Emerson, JULIE JAMMOT, Ifetayo Harvey, Harvey, Lauren Unger, Unger, Casey Hardison, Harvey didn't, Hardison, Doblin's, Baylee Ybarra Gatlin, Gatlin, negligently, There's, Michael Pollan's, Steve Jurvetson, Elon Musk's who's, Genevieve, Steve Cohen, Alexandra, Mark Zuckerberg's, Dustin Moskovitz, Cari, Gwyneth Paltrow, Paltrow, Sergey Brin, Joe Green, Green, Zuckerberg, Genevieve Jurvetson, Michael Pollan, Jonathan Lubecky, he'd, Rebekah, Robert Mercer, Elizabeth Koch, Charles Koch, Rachel Nuwer, Koch, she'd, MAPS's, Elizabeth Crystal, Joe Rogan, didn't, Jesus Christ, Crystal, Meaghan Buisson, Richard Yensen, Donna, Yensen, Buisson, weren't, Robert, Rebekah Mercer, Sean Zanni, Grof, They've, Kayla Greenstien, it's, George Sarlo who'd, Vicky Dulai, Sarlo's, Dulai, Gul Dolen, Michael Mullette, who'd, Marla Aufmuth, Mullette, Lily Kay Ross, David Nickles, Ross, Greenstien, Rick, Lenny Ignelzi, biostatisticians, Lykos, Peter Thiel, Kara Swisher, Kris Lotlikar, Federico Menapace, Mo Septimus, Handout, Monnica, Williams, Lotlikar, Henry Elkus, Helena ., Elkus, Emerson, ICER Organizations: Science, New York Jets, rockstar, Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, and Drug Administration, FDA, Business, Florida's New College, Jewish Telegraphic Agency, Sarasota Herald, Tribune, New College, Guardian, Drug, Harvard's Kennedy School of Government, eBay, Nevada, Doblin, Pentagon, Department of Veterans Affairs, Department of Defense, Staff, Corporation, PBC, pharma, New Yorker, New York Mets, Bloomberg, CBS, Breitbart, CBC News, BI, Porsche, Santa Cruz, New York Times, longtime, Mullette Corporation, New York, Health Canada, Compass, Sciences, Psychedelic Science, Whole Foods, McKinsey, Big Pharma, Vine Ventures, Lucid, Street Journal, Investments, Gawker, Publicly, PBC alums, Numinus, US Army Locations: Patagonia, Denver, Harvard, Colorado, Skokie , Illinois, Ireland, Czech, Sarasota, Arcturus, Florida, Swiss, Vietnam, Washington, Santa Cruz, Chicago, California, Iraq, British Columbia, New York, Hawaii, Santa, Nature, Moderna, Europe, Helena, Yale, Australia, Canada, Israel, Ukraine, ICER, . Upper

☆ FDA authorizes Prenosis software as first AI tool that can diagnose sepsis
▼ + stars: | 2024-04-03 | by ( Ashley Capoot | In | ) www.cnbc.com time to read: +4 min

Prenosis' tool, called Sepsis ImmunoScore, uses 22 different parameters like temperature, heart rate and cell counts to help clinicians assess a patient's risk of sepsis, the company told CNBC. While Prenosis is the first company to receive FDA approval for its AI diagnostic tool for sepsis, several organizations have built and released similar solutions. Epic's sepsis model is used in hundreds of hospitals across the U.S., according to a 2021 study published in JAMA Internal Medicine. Even so, Epic reportedly overhauled its sepsis model the following year in an attempt to improve its performance, according to Stat News. Prenosis said it worked to demonstrate the safety and efficacy of Sepsis ImmunoScore to the FDA for around 18 months.

Persons: ImmunoScore, Prenosis Organizations: U.S . Food, Drug Administration, Wednesday, Centers for Disease Control, CNBC, Johns Hopkins University, Nature Medicine, Systems, Stat News, FDA Locations: U.S, White Oak , Maryland, Chicago

☆ Cigna, Humana shares fall after report health-care giants are in talks to merge
▼ + stars: | 2023-11-29 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

Shares of Cigna and Humana slid Wednesday after a report that the two health-care giants are in talks to merge. A Cigna spokesperson did not immediately respond to CNBC's request for comment on the report from The Wall Street Journal, which cited people familiar with the matter. A Humana spokesperson declined to comment. A Cigna spokesperson at the time said the company does not comment on "rumors or speculation." Some analysts have suggested that a potential combination with Humana could be a reason for Cigna to offload its Medicare Advantage business.

Persons: Humana's, Cigna, Scott Fidel, Stephens, Fidel Organizations: Humana, Wall Street, STAT, CNBC PRO

☆ UnitedHealth pushed workers to use algorithms to cut off patient care, Stat investigation finds
▼ + stars: | 2023-11-14 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailUnitedHealth pushed workers to use algorithms to cut off patient care, Stat investigation findsBob Herman, Stat News health care reporter, joins 'Power Lunch' to discuss UnitedHealth using an algorithm to cut off patient care.

Persons: UnitedHealth, Bob Herman Organizations: Stat

☆ Why this landmark cardiac study means a bigger market for Lilly's blockbuster weight loss drug
▼ + stars: | 2023-08-09 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +7 min

A landmark study of the cardiovascular benefits of weight loss drug Wegovy is being seen as a pivotal step toward broadening access to these drugs. The drug, also known as tirzepatide, is expected to be approved for weight loss by the Food and Drug Administration by year-end. Notably, Medicare does reimburse obese patients for weight loss surgery, but Mounjaro has been able to help patients realize an average weight loss that approaches the typical success of bariatric procedures. If CMS is able to reimburse patients for weight loss treatment that would significantly increase access, boosting sales. "This is the first time a weight [loss] medicinal intervention has shown to have cardiovascular risk reduction.

Persons: enrollees, Eli Lilly, Lilly, Akash Tewari, NVO, Tewari, Wells, Mounjaro, Mohit Bansal, Robert Califf, Goldman Sachs, Chris Shibutani, Shibutani, Goldman, Refinitiv, Morgan Stanley, comorbidities, Bansal Organizations: Nordisk's Ozempic, Centers for Disease Control, Food and Drug Administration, Jefferies, Medicare, Services, GLP, STAT, Goldman, Lilly, Novo Nordisk, BMI, Novo Locations: U.S, GLP, Tuesday's

☆ A 53-year-old biotech investor is set to be replaced by a 32-year-old exec on Biogen's board. No one disclosed that the new board member is his girlfriend and the mother of his child.
▼ + stars: | 2023-06-13 | by ( Zachary Tracer | ) www.businessinsider.com time to read: +2 min

The biotech company Biogen is revamping its board of directors. The nominee, Susan Langer, is "highly qualified", Biogen said. Biogen, the $44-billion biotech company known for its work in Alzheimer's, is refreshing its board of directors. Standing for election as a replacement is Susan Langer, a 32-year-old biotech exec and former Biogen employee. Langer, a graduate of Cornell University, is the daughter of the biotech billionaire Robert Langer, known for cofounding Moderna.

Persons: wasn't, Susan Langer, Biogen, Alex Denner, Denner, Langer, Stat, Jack Cox, Ms, Cox, Denner didn't, Langer couldn't, Robert Langer, she's Organizations: Morning, Stat, Board, Stat News, Cornell University, cofounding Moderna, Souffle Therapeutics Locations: Alzheimer's, Biogen

☆ Here's what the FDA's endorsement of the Alzheimer's drug Leqembi means for Biogen
▼ + stars: | 2023-06-09 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailHere's what the FDA's endorsement of the Alzheimer's drug Leqembi means for BiogenMatt Herper, Stat News senior writer, joins 'Closing Bell: Overtime' to discuss the FDA advisers' unanimous vote to recommend Biogen Alzheimer's drug.

Persons: Matt Herper Organizations: Stat

☆ Medicare is prohibited from covering weight-loss drugs — Ozempic could change that
▼ + stars: | 2023-04-25 | by ( Lydia Ramsey Pflanzer | ) www.businessinsider.com time to read: +5 min

Medicare is prohibited from covering new weight-loss medications. Medicare, the federal program that covers healthcare for people 65 and older, is prohibited by law from covering any weight-loss medications. That includes looking at programs that test out Medicare coverage and proposed limits to coverage, The Journal reports. The future of the $100 billion weight-loss drugs marketExpanding Medicare coverage to new weight-loss medications could drastically change how Americans access the drugs. Meanwhile, other Americans will continue to go to Canada, Mexico, and unregulated online pharmacies to get the weight-loss medications for cheap.

☆ A flurry of news outside the portfolio has implications for 3 of our stocks
▼ + stars: | 2023-04-13 | by ( Jeff Marks | ) www.cnbc.com time to read: +7 min

Here are three noteworthy news developments over the past two days, which contain useful insights about our stocks. For the full year 2023, Novo now expects sales growth in the range of 24% and 30%, compared to prior estimates of 13% to 19%. In addition, operating profit growth is expected to be in the range of 28% and 34%, up from a prior range of 13% to 19%. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

☆ Sarepta drops as report says FDA almost rejected under-review gene therapy
▼ + stars: | 2023-04-13 | by ( ) www.reuters.com time to read: +1 min

April 13 (Reuters) - Sarepta Therapeutics Inc's shares (SRPT.O) fell more than 6% on Thursday as Stat News reported that the U.S. health regulator's staff were inclined to reject the company's gene therapy which is currently under review. Some staff at the U.S. Food and Drug Administration (FDA) had reached a "non-binding conclusion" that Sarepta's gene therapy should not be given approval, prompting FDA official Peter Marks to intervene and instead schedule an advisory meeting on May 12, Stat News reported, citing sources. The company is seeking approval for its gene therapy for treating a rare muscle-wasting disorder called Duchenne muscular dystrophy under the FDA's accelerated pathway. Brokerage William Blair said it still sees a "likely" approval for the therapy. Shares of Catalent Inc (CTLT.N), which holds the contract manufacturing rights for the therapy, fell as much as 5.5% in early trade.

☆ The Pfizer-Seagen deal has a hidden $1 billion warning for workers
▼ + stars: | 2023-03-13 | by ( Yeji Jesse Lee | ) www.businessinsider.com time to read: +2 min

While the deal bolsters Pfizer's cancer portfolio, it also mean cuts focused on "eliminating duplication"Pfizer said it is aiming for $1 billion in "cost efficiencies" within 3 years of the deal. Pharmaceutical giant Pfizer said on Monday that it would acquire drug developer Seagen in a massive $43 billion deal that would bolster its oncology portfolio. The acquisition is the largest biopharma deal since 2019 when AbbVie acquired Allergan for $63 billion, according to Stat News. Namely, Pfizer is aiming for $1 billion in "cost efficiencies" within three years of the deal closing, which could mean job cuts. Pfizer's deal for Seagen is expected to close in late 2023 or early 2024.

☆ FDA says sugary cereal and white bread no longer 'healthy'
▼ + stars: | 2023-02-23 | by ( Alex Bitter | ) www.businessinsider.com time to read: +3 min

Those changes mean that food companies could no longer market white bread as well as sugary cereals and yogurt as "healthy," according to the FDA. Sources of omega-3 fatty acids such as fish, for example, would get the "healthy" designation because of potential health benefits from that type of fat. The revised definition of "healthy" isn't a requirement for food companies, according to the FDA. Even so, many food companies closely follow nonbinding FDA guidelines. Another set of proposed FDA guidelines for plant-based milks, for example, drew ire from the dairy industry this week.

☆ Kamala Harris swipes at DeSantis using his 'vanguard of freedom' inauguration quote, on the governor's home turf, as she announces new moves on abortion pill
▼ + stars: | 2023-01-22 | by ( Kimberly Leonard | ) www.businessinsider.com time to read: +10 min

said Harris, who didn't use DeSantis' name but was quoting directly from his January 3 inauguration speech. The vice president, who has been at the forefront voice for the administration's on abortion rights, announced that President Joe Biden would be signing a memorandum to make abortion pills easier to access. Sunday would have marked the 50th anniversary of Roe v. Wade, the Supreme Court ruling that guaranteed a national right to abortion. Wilfredo Lee/AP PhotoFlorida has other ways of expanding abortion rightsAbortion rights proved to be a liability for Republicans in the November midterms. Reproductive rights groups are working to put the issue of abortion before Florida voters through a 2024 ballot measure.

☆ Kamala Harris swipes at DeSantis using his 'vanguard of freedom' quote, on the governor's home turf, as she announces new moves on abortion pill
▼ + stars: | 2023-01-22 | by ( Kimberly Leonard | ) www.businessinsider.com time to read: +11 min

said Harris, who didn't use DeSantis' name but was quoting directly from his 2022 State of the State address. The vice president, who has been at the forefront voice for the administration's on abortion rights, announced that President Joe Biden would be signing a memorandum to make abortion pills easier to access. Sunday would have marked the 50th anniversary of Roe v. Wade, the Supreme Court ruling that guaranteed a national right to abortion. Wilfredo Lee/AP PhotoFlorida has other ways of expanding abortion rightsAbortion rights proved to be a liability for Republicans in the November midterms. Reproductive rights groups are working to put the issue of abortion before Florida voters through a 2024 ballot measure.

☆ Acţiuni de 5,6 milioane de dolari, vândute de șeful Pfizer într-o zi
▼ + stars: | 2019-01-01 | by ( Știri Din Moldova | ) stiri.md time to read: +3 min

Bourla a vândut 132.508 acţiuni la un preţ mediu de 41,94 dolari pe acţiune, în valoare de aproape 5,6 milioane dolari, conform documentelor depuse la autoritate de reglementare. “După o prezenţă de peste 25 de ani în companie, Albert deţine o cantitate substanţială de acţiuni Pfizer în cadrul planurilor noastre de economii calificate şi necalificate. ”Acum deţine de nouă ori salariul său în acţiuni Pfizer, după vânzarea săptămâna aceasta”, a declarat un purtător de cuvânt al Pfizer într-o declaraţie. De nouă ori acel salariu ar reprezenta acţiuni în valoare de aproximativ 15 milioane de dolari. Pfizer a participat la Operaţiunea Warp Speed acceptând bani pentru achiziţionarea şi distribuirea dozelor de vaccin, dar finanţarea federală nu s-a îndreptat spre dezvoltarea vaccinului.

Persons: Albert Bourla, Bourla, Pfizer, Albert deţine, Jay Clayton Organizations: Black, Moderna Locations: Germania, acţiunile, SUA

Search resuls for: "Stat News"

15 mentions found